Pancreatic Duct Lavage Cytology Combined with a Cell-block Method for Patients with Possible Pancreatic Ductal Adenocarcinomas, Including Pancreatic Carcinoma in Situ
Overview
Authors
Affiliations
Background/aims: This study aimed to clarify the efficacy and safety of pancreatic duct lavage cytology combined with a cell-block method (PLC-CB) for possible pancreatic ductal adenocarcinomas (PDACs).
Methods: This study included 41 patients with suspected PDACs who underwent PLC-CB mainly because they were unfit for undergoing endoscopic ultrasonography-guided fine needle aspiration. A 6-Fr double lumen catheter was mainly used to perform PLC-CB. Final diagnoses were obtained from the findings of resected specimens or clinical outcomes during surveillance after PLC-CB.
Results: Histocytological evaluations using PLC-CB were performed in 87.8% (36/41) of the patients. For 31 of the 36 patients, final diagnoses (invasive PDAC, 12; pancreatic carcinoma in situ, 5; benignancy, 14) were made, and the remaining five patients were excluded due to lack of surveillance periods after PLC-CB. For 31 patients, the sensitivity, specificity, and accuracy of PLC-CB for detecting malignancy were 94.1%, 100%, and 96.8%, respectively. In addition, they were 87.5%, 100%, and 94.1%, respectively, in 17 patients without pancreatic masses detectable using endoscopic ultrasonography. Four patients developed postprocedural pancreatitis, which improved with conservative therapy.
Conclusion: PLC-CB has an excellent ability to detect malignancies in patients with possible PDACs, including pancreatic carcinoma in situ.
Rakhshani N, Soleimani N, Aghaei S, Barakat R, Keshtvarz Hesam Abadi A Iran J Pathol. 2025; 20(1):98-107.
PMID: 40060228 PMC: 11887639. DOI: 10.30699/ijp.2024.2036290.3329.
Otsuka Y, Minaga K, Hara A, Yamao K, Takenaka M, Chikugo T Endosc Int Open. 2024; 12(6):E764-E766.
PMID: 38847017 PMC: 11156511. DOI: 10.1055/a-2317-0520.
Rerknimitr R Clin Endosc. 2023; 56(3):313-314.
PMID: 37081798 PMC: 10244147. DOI: 10.5946/ce.2023.029.